Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (151-160 of 243) with videos related to

Pageof 25
Sort By:
Cell & Bioscience|September 11, 2022
Three-dimensional in vitro culture models in oncology researchCamille Jubelin, Javier Muñoz-Garcia, Laurent Griscom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of Midostaurin in vivoBénédicte Brounais, Céline Chipoy, Kanji Mori, et al.
Molecular Cancer Research : MCR|January 20, 2012
A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanismsGaëlle Picarda, Sylvanie Surget, Romain Guiho, et al.
Biomolecules|May 16, 2023
Engineering of a Bispecific Nanofitin with Immune Checkpoint Inhibitory Activity Conditioned by the Cross-Arm Binding to EGFR and PDL1Perrine Jacquot, Javier Muñoz-Garcia, Maurine Fleury, et al.
Journal of Lipid Research|May 1, 2020
Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosisVincent Mignard, Nolwenn Dubois, Didier Lanoé, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracerElisabeth Miot-Noirault, François Gouin, Aurélien Vidal, et al.
Cancers|April 12, 2022
Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in OsteosarcomaJavier Muñoz-Garcia, Jorge William Vargas-Franco, Bénédicte Brounais-Le Royer, et al.
Biomolecules|April 30, 2025
A Multispecific Checkpoint Inhibitor Nanofitin with a Fast Tumor Accumulation Property and Anti-Tumor Activity in Immune Competent MicePerrine Jacquot, Javier Muñoz-Garcia, Antoine Léger, et al.
Cancer Research|January 17, 2009
Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcomaFrancois Lamoureux, Gaëlle Picarda, Laure Garrigue-Antar, et al.
International Journal of Cancer|December 5, 2014
Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitmentAude I Ségaliny, Amel Mohamadi, Blandine Dizier, et al.
Pageof 25

Showing results (151-160 of 243) with videos related to

Sort By:
Pageof 25
Cell & Bioscience|September 11, 2022
Three-dimensional in vitro culture models in oncology researchCamille Jubelin, Javier Muñoz-Garcia, Laurent Griscom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of Midostaurin in vivoBénédicte Brounais, Céline Chipoy, Kanji Mori, et al.
Molecular Cancer Research : MCR|January 20, 2012
A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanismsGaëlle Picarda, Sylvanie Surget, Romain Guiho, et al.
Biomolecules|May 16, 2023
Engineering of a Bispecific Nanofitin with Immune Checkpoint Inhibitory Activity Conditioned by the Cross-Arm Binding to EGFR and PDL1Perrine Jacquot, Javier Muñoz-Garcia, Maurine Fleury, et al.
Journal of Lipid Research|May 1, 2020
Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosisVincent Mignard, Nolwenn Dubois, Didier Lanoé, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracerElisabeth Miot-Noirault, François Gouin, Aurélien Vidal, et al.
Cancers|April 12, 2022
Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in OsteosarcomaJavier Muñoz-Garcia, Jorge William Vargas-Franco, Bénédicte Brounais-Le Royer, et al.
Biomolecules|April 30, 2025
A Multispecific Checkpoint Inhibitor Nanofitin with a Fast Tumor Accumulation Property and Anti-Tumor Activity in Immune Competent MicePerrine Jacquot, Javier Muñoz-Garcia, Antoine Léger, et al.
Cancer Research|January 17, 2009
Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcomaFrancois Lamoureux, Gaëlle Picarda, Laure Garrigue-Antar, et al.
International Journal of Cancer|December 5, 2014
Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitmentAude I Ségaliny, Amel Mohamadi, Blandine Dizier, et al.
Pageof 25